Seasonal Changes in Prescribing of Long-Acting beta-2-agonists-containing Drugs

Jul-15

AUTHORS : Marietta Rottenkolber (Details from study: a Institute for Medical Information Sciences, Biometry, and Epidemiology, Ludwig-MaximiliansUniversitaet Muenchen, Marchioninistr. 15, D-81377 Munich, Germany – Email: rottenk@ibe.med.uni-muenchen.de) now works at LMU Clinic , Diabetes Research Group: Marietta.Rottenkolber@med.uni-muenchen.de OR Dr Mark C. H. de Groot, Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht University, PO Box 80082, Utrecht, TB 3508, The Netherlands / UMC Utrecht, Heidelberglaan 100, 3584 CX Utrecht, Netherlands – E-mail: M.C.H.deGroot@uu.nl / mgroot3@umcutrecht.nl – Profile: https://www.umcutrecht.nl/en/research/researchers/de-groot-mark-mch

JOURNAL : Respiratory Medicine

REFERENCE: 109(7):828-37

DOI : 10.1016/j.rmed.2015.01.010

Seasonal Changes in Prescribing of Long-Acting beta-2-agonists-containing Drugs

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study